The reductive metabolism of diaziquone (AZQ) in the S9 fraction of MCF-7 cells: Free radical formation and NAD(P)H: Quinone-acceptor oxidoreductase (DT-diaphorase) activity

This publication has 24 references indexed in Scilit:

• Mechanism(s) of bioreductive activation: The example of diaziquinone (AZQ)
  Free Radical Biology & Medicine, 1989
• Caffeine, aminoimidazolecarboxamide and dicoumarol, inhibitors of NAD(P)H dehydrogenase (quinone) (DT diaphorase), prevent both the cytotoxicity and DNA interstrand crosslinking produced by 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) in walker cells
  Biochemical Pharmacology, 1989
• DT-diaphorase-catalysed reduction of 1,4-naphthoquinone derivatives and glutathionyl-quinone conjugates. Effect of substituents on autoxidation rates
  Biochemical Journal, 1989
• DT-diaphorase-catalyzed two electron reduction of quinone epoxides
  Free Radical Biology & Medicine, 1987
• Differential formation of hydroxyl radicals by adriamycin in sensitive and resistant MCF-7 human breast tumor cells: implications for the mechanism of action
  Biochemistry, 1987
• Overview of enzyme systems involved in bioreduction of drugs and in redox cycling
  Biochemical Pharmacology, 1986
• Diaziquone given as a continuous infusion is an active agent for relapsed adult acute nonlymphocytic leukemia
  Blood, 1986
• Mechanism for the Reductive Activation of Diaziquone
  Journal of Pharmaceutical Sciences, 1985
• Treatment of patients with recurrent primary brain tumors with AZQ
  Neurology, 1984
• [56] DT diaphorase
  Published by Elsevier ,1967